
Ellis Levine
Hematology/Medical Oncology Fellowship Program Director · ROSWELL PARK CANCER INSTITUTE
Credentials: · · · ·
History
- Present
Hematology/Medical Oncology Fellowship · ROSWELL PARK CANCER INSTITUTE
- 1982–1984
- 1979–1982
Research
Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer
Journal of Clinical Oncology · 2003 · 562 citations
Nonrandom chromosome abnormalities in lymphoma
Cancer Research · 1983 · 356 citations
Barriers to clinical trial participation by older women with breast cancer
Journal of Clinical Oncology · 2003 · 311 citations
- TO
16 papers

13 papers
- BP
12 papers
- CB
12 papers

12 papers
- BR
11 papers
- JS
11 papers
- RM
11 papers
Grants
- 2019–2026
Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute
National Cancer Institute · UG1
Contact PI · $3.1M · Roswell Park Cancer Institute Corp
- 2014–2019
Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.
National Cancer Institute · U10
Contact PI · $2.9M · Roswell Park Cancer Institute Corp
- 1993–2015
Cancer and Leukemia Group B: RPCI/SUNYAB
National Cancer Institute · U10
Contact PI · $5.5M · Roswell Park Cancer Institute Corp
Clinical trials
- 2024–2025
Principal investigator · Terminated · Phase 1, Phase 2
Roswell Park Cancer Institute
- 2023–2029
Principal investigator · Recruiting
Roswell Park Cancer Institute
- 2019–2029
Principal investigator · Recruiting
Roswell Park Cancer Institute
- 2019–2027
Principal investigator · Recruiting · Phase 2
Roswell Park Cancer Institute


